Chondroitin-ACOS ointment for external use 5%, 30g

Composition

>

of 100 g of ointment contains:

active ingredients:

chondroitin sodium sulfate (in terms of dry matter) 5 g,

dimexide (dimethyl sulfoxide) 10 g,

excipients (base):

lanolin anhydrous;

medical vaseline;

purified water

Pharmacological action

Chondroitin-AKOS has a chondroprotective, stimulating regeneration of cartilage tissue, anti-inflammatory, analgesic effect.

Pharmacodynamics

Chondroitin-AKOS contains chondroitin sulfate, a joint cartilage repair stimulator (chondroprotector) derived from bovine tracheal cartilage, and dimethyl sulfoxide.

Chondroitin sulfate is a high-molecular mucopolysaccharide that inhibits the destruction of cartilage tissue and accelerates its recovery. Suppresses enzymes that cause damage to cartilage tissue and prevents its degradation; stimulates the biosynthesis of glycosaminoglycans by chondrocytes; promotes the restoration of the articular bag and cartilage surfaces of joints, increases the production of intra-articular fluid.

Improves phosphorus-calcium metabolism and reduces calcium loss in cartilage tissue, slows down bone resorption, normalizes metabolism in hyaline tissue, accelerates regeneration (recovery) and slows down the processes of degeneration (destruction) of cartilage tissue. Structurally similar to heparin, it prevents the formation of fibrin clots in the synovial and subchondral microcirculation. As a result of exposure, the soreness decreases and the mobility of the affected joints increases.

Dimethyl sulfoxide, which is part of the ointment, has anti-inflammatory, analgesic and fibrinolytic effects, promotes better penetration of chondroitin sulfate through cell membranes deep into tissues.

Chondroitin-AKOS ointment has analgesic and anti-inflammatory effect, normalizes metabolism and stimulates recovery processes in joint tissues, reduces or disappears joint soreness, improves joint mobility, and slows down the progression of osteoarthritis and osteochondrosis.

Indications

Treatment and prevention of osteochondrosis, osteoarthritis of peripheral joints and spine.

Use during pregnancy and lactation

Do not use Chondroitin-AKOS ointment without consulting a doctor during pregnancy and lactation, as well as in childhood.

Contraindications

• Hypersensitivity to the components of the drug Chondroitin-AKOS.
• acute inflammatory processes in the wound area;
• widespread tissue necrosis;
• excessive granulation;
• violation of the integrity of the skin in the places of intended application.

With caution: do not use Chondroitin-AKOS ointment without consulting a doctor during pregnancy and lactation, as well as in childhood.

Side effects

in rare cases, allergic reactions may occur that require discontinuation of the drug.

Interaction

there were no cases of negative drug interaction when prescribing the ointment against the background of therapy with other drugs included in the generally accepted treatment regimens for degenerative diseases of the joints and spine.

How to take, course of use and dosage

Externally.

Chondroitin-AKOS ointment is applied 2-3 times a day to the skin above the lesion and rubbed in for 2-3 minutes until completely absorbed.

Usually, the course of treatment is from 2-3 weeks to 2 months.

If necessary, the course of treatment is repeated.

Special instructions

avoid contact with the ointment on the mucous membranes and open wounds.

Form of production

Ointment

Storage conditions

In a dark place, at a temperature of 2-20 °C

Shelf life

3 years

Active ingredient

Chondroitin sulfate

Dosage form

ointment

Description

Children as prescribed by a doctor, For adults, Pregnant women as prescribed by a doctor, Nursing mothers as prescribed by a doctor

Indications

Arthritis, Osteoarthritis, Osteoarthritis, Osteochondrosis